View drug registration information details.


ItemsRegistration information
ID2185
No2185
Brand NameEZIUM
IngredientsESOMEPRAZOLE MAGNESIUM 22.5 % PELLETS EQ.TO ESOMEPRAZOLE 40 MG
Dosage FormCAPSULE
Primary PackagingALU-BLISTER
Storage
Shelf Life3 YEARS
Pack Size2 X 7 CAPSULES/BOX
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsGASTROESOPHAGEAL REFLUX DISEASE, TREATMENT OF EROSIVE REFLUX ESOPHAGITIS, LONG TERM MANAGEMENT OF PATIENTS WITH HEALED ESOPHAGITIS TO PREVENT RELAPSE, SYMPTOMATIC TREATMENT OF GERD WITHOUT ESOPHAGITIS. AS A TRIPLE THERAPY(ESOMEPRAZOLE + AMOXICILLIN +CLARITHROMYCIN) FOR THE ERADICATION OF HELICOBACTER PYLORI, HEALING OF DUODENAL ASSOCIATED WITH H.PYLORI INFECTION, PREVENTION OF RELAPSE OF PEPTIC ULCERS IN PATIENTS WITH H.PYLORI, ASSOCIATED ULCERS
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionOPAQUE, DARK PURPLE, HARD GELATIN CAPSULES, CONTAINING OFF WHITE ENTERIC COATED PELLETS,SIZE NO 3, EZIUM 40 PRINTED ON BODY
Note
License OwnerPOUNSAB PHARMA CO.,LTD
ManufacturerTHE SEARLE COMPANY LIMITED
CountryPAKISTAN
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No02 I 4902/20
FDD Registration Date19-Apr-2023
Expiry Date18-Apr-2026

Back to drug list